<!DOCTYPE html SYSTEM "about:legacy-compat"><html lang="en-US" data-colors-preset="contrast" data-primary-color="#307FFF"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="UTF-8"><meta name="robots" content="noindex">  <meta name="built-on" content="2024-01-01T12:25:14.7124043"><meta name="build-number" content="${buildNumber}">       <title>阿斯利康的Tagrisso-化疗组合疗法获FDA授予优先审评权 | 20231016</title><script id="virtual-toc-data" type="application/json">[]</script><script id="topic-shortcuts" type="application/json"></script><link href="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.css" rel="stylesheet">   <link rel="apple-touch-icon" sizes="180x180" href="https://jetbrains.com/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="https://jetbrains.com/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="https://jetbrains.com/favicon-16x16.png"><link rel="manifest" href="https://jetbrains.com/site.webmanifest"><link rel="mask-icon" href="https://jetbrains.com/safari-pinned-tab.svg" color="#000000"><meta name="msapplication-TileColor" content="#000000"/><meta name="msapplication-TileImage" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-144x144.png"/><meta name="msapplication-square70x70logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-70x70.png"/><meta name="msapplication-square150x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-150x150.png"/><meta name="msapplication-wide310x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x150.png"/><meta name="msapplication-square310x310logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x310.png"/>  <meta name="image" content=""><!-- Open Graph --><meta property="og:title" content="阿斯利康的Tagrisso-化疗组合疗法获FDA授予优先审评权 | 20231016"/><meta property="og:description" content=""/><meta property="og:image" content=""/><meta property="og:site_name" content="20231016 Help"/><meta property="og:type" content="website"/><meta property="og:locale" content="en_US"/><meta property="og:url" content="1967.html"/><!-- End Open Graph --><!-- Twitter Card --><meta name="twitter:card" content="summary_large_image"><meta name="twitter:site" content=""><meta name="twitter:title" content="阿斯利康的Tagrisso-化疗组合疗法获FDA授予优先审评权 | 20231016"><meta name="twitter:description" content=""><meta name="twitter:creator" content=""><meta name="twitter:image:src" content=""><!-- End Twitter Card --><!-- Schema.org WebPage --><script type="application/ld+json"> { "@context": "http://schema.org", "@type": "WebPage", "@id": "1967.html#webpage", "url": "1967.html", "name": "阿斯利康的Tagrisso-化疗组合疗法获FDA授予优先审评权 | 20231016", "description": "", "image": "", "inLanguage":"en-US" }</script><!-- End Schema.org --><!-- Schema.org WebSite --><script type="application/ld+json"> { "@type": "WebSite", "@id": "/#website", "url": "/", "name": "20231016 Help" }</script><!-- End Schema.org --></head>      <body data-id="1967" data-main-title="阿斯利康的Tagrisso-化疗组合疗法获FDA授予优先审评权" data-article-props="{&quot;seeAlsoStyle&quot;:&quot;links&quot;}"  data-template="article"  data-breadcrumbs=""  >   <div class="wrapper"><main class="panel _main"><header class="panel__header"><div class="container"><h3>20231016  Help</h3><div class="panel-trigger"></div></div></header><section class="panel__content"><div class="container"><article class="article" data-shortcut-switcher="inactive"><h1 data-toc="1967"   id="1967.md">阿斯利康的Tagrisso-化疗组合疗法获FDA授予优先审评权</h1>  <p id="3e1a2b7e_15"><span class="control" id="3e1a2b7e_16">2023-10-16 07:42</span></p><p id="3e1a2b7e_17"><span class="control" id="3e1a2b7e_18">https://www.gelonghui.com/live/1248971</span></p><p id="3e1a2b7e_19">格隆汇10月16日｜阿斯利康旗下靶向药物Tagrisso与化疗联合治疗一种肺癌的方案已被美国食品和药物管理局(FDA)接受并授予优先审查权。监管机构的决定是基于一项晚期试验，该试验将中位无进展生存期(PFS)延长了近9个月。无进展生存期指的是患者在治疗后疾病没有恶化的情况下的生存时间。Tagrisso在2023年上半年的销售额达到29.2亿美元，目前已在包括美国、欧盟、中国和日本在内的100多个国家或地区被批准作为单一疗法使用。</p><div class="last-modified"> Last modified: 01 一月 2024</div><div data-feedback-placeholder="true"></div><div class="navigation-links _bottom">  <a class="navigation-links__prev" href="1968.html">格隆汇10月16日｜京沪高铁：预计前三季度净利润为82.53亿元到96.62亿元，上年同期净利润1.52亿元。</a>   <a class="navigation-links__next" href="1966.html">消息称英伟达下一代B100提前至明年Q2发布 SK海力士将独家供应HBM3E</a>  </div></article><div id="disqus_thread"></div></div></section></main></div>  <script src="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.js"></script></body></html>